Joffre F, Rousseau H, Aziza R
Service de Radiologie, Hôpital de Rangueil, Toulouse.
Ann Radiol (Paris). 1992;35(4 Pt 2):288-92.
The efficacy and safety of Optiray (ioversol), a new low osmolar non-ionic contrast agent were compared with Iopamiron in a double-blind randomized trial for intravenous pyelography. Concerning the diagnostic efficacy, Optiray 300 was equivalent to Iopamiron 370 for identical injection volumes. Significantly less reinjections were necessary with Optiray. Tolerability was found to be excellent, equivalent to the reference product. Optiray was found to be both well tolerated and of satisfactory diagnostic value.
在一项关于静脉肾盂造影的双盲随机试验中,将新型低渗非离子型造影剂碘佛醇(欧乃派克)的有效性和安全性与碘帕醇进行了比较。在诊断有效性方面,相同注射量时碘佛醇300与碘帕醇370相当。使用碘佛醇时需要再次注射的情况明显更少。耐受性良好,与参比产品相当。碘佛醇耐受性良好且诊断价值令人满意。